RG
Renee D Gala
President & CEODirector

Renee D Gala insider trades: Jazz Pharmaceuticals (JAZZ) stock buys and sales

President & CEO, Jazz Pharmaceuticals Last trade Nov 3, 2026 59 Form 4 filings
$698K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2015
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Renee reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 3, 2026JAZZ↓ Sell$225K
Oct 6, 2026JAZZ↓ Sell$473K
May 18, 2023JAZZ↓ Sell$790K
Dec 21, 2022JAZZ↓ Sell$422K
Aug 15, 2018TBPH↓ Sell$1.2M
May 18, 2018TBPH↓ Sell$243K
Mar 7, 2018CORT↑ Buy$155K
Aug 17, 2015TBPH↑ Buy$122K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other JAZZ insiders

Open-market trades in the last 12 months

About Renee D Gala's insider trades

Renee D Gala is President & CEO at Jazz Pharmaceuticals (JAZZ). Since Aug 17, 2015, Renee has reported 2 open-market purchases worth $277K and 6 sales worth $3.3M on SEC Form 4. In the last 12 months: 2 sales ($698K).

Their filings also include grants and awards (29 filings), shares withheld for taxes (26 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JAZZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.